by QFR Solutions | Jun 28, 2018 | News
Source: Reuters Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world’s biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy benefit managers. The deal’s...
by angelliu | Jun 4, 2018 | News
Source: FierceBiotech Verrica Pharmaceuticals has filed to raise $86 million from public investors. The planned IPO will give Verrica the money it needs to take a treatment for viral skin infection molluscum through phase 3 and onto the market. West Chester,...
by angelliu | Jun 4, 2018 | News
Source: Japan’s Takeda Pharmaceutical is about to become a major international player on the biopharma scene, with its purchase of larger Irish rival Shire (SHPG, +1.41%). It’s one of the biggest pharma deals in history, and the largest-ever international...
by qfrsolutions | May 1, 2018 | News
Source: Business Wire MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announces today the availability of a new topical product, IMPOYZ Cream, indicated for the treatment of moderate to severe plaque psoriasis in patients 18 years of age or older....
by qfrsolutions | Apr 30, 2018 | News
Source: PR Newswire SAN FRANCISCO, April 30, 2018 /PRNewswire/ — Datavant, the leader in helping healthcare organizations safely link their data to improve medical research and patient care, today announced that it has acquired Universal Patient Key (UPK), the...
by qfrsolutions | Mar 22, 2018 | News
Source: “Sun Pharma” and includes its subsidiaries and/or associate companies) announced that the U.S. Food and Drug Administration (FDA) has approved ILUMYA™ (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis...
